To substantiate the prognostic significance of our model, we recruited a clinical cohort consisting of 20 patients with head and neck squamous cell carcinoma at various clinical stages to verify the expression of the four genes (CCND1, FTH1, YWHAG and TNFRSF12A). This evidence concerns the gene FTH1 and head and neck squamous cell carcinoma.